Abstract

CASE STYDY: BREATHLESSNESS AFTER COVID-19 VACCINATION AND USE OF FORMOTEROL FUMARATE AND BUDESONIDE INHALER FOR MANAGEMENT

*Kaushik M. and Srikant

.

Abstract

Coronavirus disease 2019 (COVID-19) is one of the biggest challenge threatening globally. First case of novel corona virus was detected in Wuhan, China in late 2019. Since then it has spread globally creating worldwide health, socioeconomic and humanitarian crisis. It has cost lakhs of lives globally including India. Since its outbreak in late 2019, the virus has spread globally, creating global health, socioeconomic and humanitarian crises. In record breaking time vaccines were invented and approved by world health organization (WHO) and regulatory agencies for emergency use to limit the spread of Covid-19, even before the completion of conventional phases of clinical trials. However reported side effects of these vaccines are mild to moderate with very rare cases of serious adverse outcomes like myocarditis. We describe a case of healthy young female who develop respiratory problems after COVID vaccination.

Keywords: COVID-19, COVID-19 vaccine, Adverse reactions, Clinical trials, Vaccination, Pharmacovigilance.